MedTech News
Scientists create 4D ultrasound
What if we could watch blood move through an entire organ in real time?
Researchers turn cancer resistance mutations into targets for new immunotherapies
One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs that are initially effective lose their potency over time, as malignant cells acquire mutations that enable them to survive and spread.
AI model predicts blood loss in liposuction
A newly developed artificial intelligence (AI) model is highly accurate in predicting blood loss in patients undergoing high-volume liposuction, reports a study in the Plastic and Reconstructive Surgery journal.
Alzheimer’s disease can be reversed in animal models to achieve full neurological recovery
Now, a research team from University Hospitals, Case Western Reserve University, and the Louis Stokes Cleveland VA Medical Center has challenged this long-held dogma in the field. They tested whether brains already badly afflicted with advanced AD could recover.
MannKind earns FDA nod for on-body infusor, new autoinjector patents
MannKind (Nasdaq:MNKD) announced today that the FDA approved its Furoscix (furosemide) on-body infusor for pediatric patients.
One pull of a string is all it takes to deploy these complex structures
A new method could enable users to design portable medical devices, like a splint, that can be rapidly converted from flat panels to a 3D object without any tools.
Edwards wins FDA approval for Sapien M3 mitral valve, marking first transseptal transcatheter therapy
Edwards Lifesciences (NYSE: EW)+
has won FDA approval for its Sapien M3 mitral valve replacement system for treating mitral regurgitation (MR).
Monoclonal antibody shows promising results for rare liver disease
A multicenter study led by UC Davis Health has tested a new treatment designed to improve care for people with a rare liver disease called primary sclerosing cholangitis. Researchers learned that an anti-inflammatory and anti-fibrotic monoclonal antibody known as nebokitug was safe and showed potential efficacy in patients with PSC.